Y. Godet, A. Moreau-aubry, Y. Guilloux, V. Vignard, A. Khammari et al., MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, The Journal of Experimental Medicine, vol.6, issue.11, pp.2673-2682, 2008.
DOI : 10.1038/76292

Y. Godet, A. Moreau-aubry, D. Mompelat, V. Vignard, A. Khammari et al., An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context, Cancer Immunology, Immunotherapy, vol.19, issue.3, pp.431-439, 2010.
DOI : 10.1007/s00262-009-0762-z

D. Carbonnelle, V. Vignard, D. Sehedic, A. Moreau-aubry, L. Florenceau et al., The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences, PLoS ONE, vol.413, issue.9, p.75233, 2013.
DOI : 10.1371/journal.pone.0075233.s003

Y. Godet, J. Desfrancois, V. Vignard, D. Schadendorf, A. Khammari et al., Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy, European Journal of Immunology, vol.42, issue.6, pp.1786-1794, 2010.
DOI : 10.1002/eji.200940132

M. Bobinet, V. Vignard, A. Rogel, A. Khammari, B. Dreno et al., MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients, PLoS ONE, vol.60, issue.12, p.51716, 2012.
DOI : 10.1371/journal.pone.0051716.t001

A. Rogel, V. Vignard, M. Bobinet, N. Labarriere, and F. Lang, P018. A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope, Melanoma Research, vol.21, pp.327-337, 2011.
DOI : 10.1097/01.cmr.0000399479.31979.e8

M. Bobinet, V. Vignard, L. Florenceau, F. Lang, N. Labarriere et al., Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation, PLoS ONE, vol.130, issue.9, p.75421, 2013.
DOI : 10.1371/journal.pone.0075421.g005

F. Gueugnon, S. Leclercq, C. Blanquart, C. Sagan, L. Cellerin et al., Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma, The American Journal of Pathology, vol.178, issue.3, pp.1033-1042, 2011.
DOI : 10.1016/j.ajpath.2010.12.014

S. Lucas, N. Van-baren, C. De-smet, and P. Coulie, Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples, International Journal of Cancer, vol.19, issue.8, pp.1960-1966, 2012.
DOI : 10.1002/ijc.26198

D. Smet, C. Loriot, A. Boon, and T. , Promoter-Dependent Mechanism Leading to Selective Hypomethylation within the 5' Region of Gene MAGE-A1 in Tumor Cells, Molecular and Cellular Biology, vol.24, issue.11, pp.4781-4790, 2004.
DOI : 10.1128/MCB.24.11.4781-4790.2004

A. Blattler and P. Farnham, Cross-talk between Site-specific Transcription Factors and DNA Methylation States, Journal of Biological Chemistry, vol.288, issue.48, pp.34287-34294, 2013.
DOI : 10.1074/jbc.R113.512517
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843044

L. Dinten, N. Pul, A. Van-nieuwpoort, C. Out, M. Jager et al., Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens, Investigative Opthalmology & Visual Science, vol.46, issue.1, pp.24-30, 2005.
DOI : 10.1167/iovs.04-0961

A. Query, . Lippincott, . Williams, . Wilkins, . Name et al., Details Required Author's Response Q1 Please provide the department for affiliation